Bayer AG develops and commercializes a wide range of products designed to improve human and plant health. The company's Pharmaceuticals division focuses on prescription drugs for cardiology, oncology, women's health, and hematology, as well as specialty therapeutics and diagnostic imaging equipment. The Consumer Health segment offers over-the-counter medicines, nutritional supplements, and dermatology products. The Crop Science division, significantly expanded by the 2018 acquisition of Monsanto, provides high-value seeds, chemical and biological crop protection solutions, and digital farming tools. Geographically, Bayer derives its revenue globally, with its largest markets being North America and Europe.
